International Medical University, Kuala Lumpur, Malaysia.
Center for Bioethics, Harvard Medical School, Boston, Massachusetts.
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2021-055702.
When incentives are offered to parents and their children to partake in research, there are concerns that parents may be unduly influenced by the incentives, and the children may be exploited. We present a case from a low- and middle-income country and consider the ethical issues that arise when the children are asked to participate in a multinational, double-blind, randomized, placebo-controlled trial of the effects of a nutritional supplement on growth. The first commenter, from Malaysia, notes that their residents might not share Americans' expectations regarding children's role in the consent process from a cultural perspective, which may alter the analysis of the concerns. The authors of the second commentary emphasize the use of incentives that benefit the child participant rather than their parent or are provided directly to the child participant to address the concerns. The third commentator discusses the importance of minimizing the study's risks and balancing the benefits and the risks, which attenuates the concerns.
当向父母及其子女提供参与研究的激励措施时,人们担心父母可能会受到激励措施的不当影响,而子女可能会受到剥削。我们提出了一个来自中低收入国家的案例,并考虑了当儿童被要求参与一项关于营养补充剂对生长影响的跨国、双盲、随机、安慰剂对照试验时出现的伦理问题。来自马来西亚的第一位评论员指出,从文化角度来看,他们的居民可能不会像美国人那样期望儿童在同意过程中发挥作用,这可能会改变对这些问题的分析。第二篇评论的作者强调了使用对儿童参与者有益而不是对其父母有益的激励措施,或者直接提供给儿童参与者,以解决这些问题。第三位评论员讨论了最小化研究风险和平衡收益与风险的重要性,这减轻了人们的担忧。